Nippon Chemiphar Co., Ltd. (4539.T)
JPY 1512.0
(-0.13%)
JPY 1512.0
(-0.13%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 16.98 Billion JPY | 11.5% |
| 2022 | 15.23 Billion JPY | 2.99% |
| 2021 | 14.78 Billion JPY | -3.77% |
| 2020 | 15.36 Billion JPY | 1.77% |
| 2019 | 15.09 Billion JPY | -3.37% |
| 2018 | 15.62 Billion JPY | 4.09% |
| 2017 | 15.01 Billion JPY | -0.9% |
| 2016 | 15.14 Billion JPY | 13.54% |
| 2015 | 13.34 Billion JPY | 3.35% |
| 2014 | 12.9 Billion JPY | 2.75% |
| 2013 | 12.56 Billion JPY | 6.92% |
| 2012 | 11.75 Billion JPY | -3.2% |
| 2011 | 12.13 Billion JPY | 6.74% |
| 2010 | 11.37 Billion JPY | -5.1% |
| 2009 | 11.98 Billion JPY | 26.8% |
| 2008 | 9.45 Billion JPY | 86.01% |
| 2007 | 5.08 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 17.79 Billion JPY | 4.78% |
| 2024 Q2 | 18.07 Billion JPY | 1.61% |
| 2023 FY | 16.98 Billion JPY | 11.5% |
| 2023 Q2 | 16.99 Billion JPY | -3.9% |
| 2023 Q4 | 16.98 Billion JPY | -3.89% |
| 2023 Q1 | 17.68 Billion JPY | 16.12% |
| 2023 Q3 | 17.66 Billion JPY | 3.97% |
| 2022 Q2 | 16.23 Billion JPY | -4.32% |
| 2022 Q1 | 16.96 Billion JPY | 14.71% |
| 2022 Q3 | 16.01 Billion JPY | -1.32% |
| 2022 FY | 15.23 Billion JPY | 2.99% |
| 2022 Q4 | 15.23 Billion JPY | -4.91% |
| 2021 Q3 | 15.64 Billion JPY | -1.73% |
| 2021 FY | 14.78 Billion JPY | -3.77% |
| 2021 Q1 | 16.69 Billion JPY | 8.65% |
| 2021 Q2 | 15.92 Billion JPY | -4.62% |
| 2021 Q4 | 14.78 Billion JPY | -5.5% |
| 2020 Q2 | 16.54 Billion JPY | -2.84% |
| 2020 Q1 | 17.02 Billion JPY | 12.74% |
| 2020 Q3 | 16.13 Billion JPY | -2.47% |
| 2020 FY | 15.36 Billion JPY | 1.77% |
| 2020 Q4 | 15.36 Billion JPY | -4.74% |
| 2019 Q1 | 16.45 Billion JPY | 5.29% |
| 2019 Q2 | 16.45 Billion JPY | 0.04% |
| 2019 FY | 15.09 Billion JPY | -3.37% |
| 2019 Q4 | 15.09 Billion JPY | -5.8% |
| 2019 Q3 | 16.02 Billion JPY | -2.61% |
| 2018 Q2 | 16.17 Billion JPY | 0.8% |
| 2018 Q3 | 16.02 Billion JPY | -0.95% |
| 2018 FY | 15.62 Billion JPY | 4.09% |
| 2018 Q4 | 15.62 Billion JPY | -2.47% |
| 2018 Q1 | 16.04 Billion JPY | 6.89% |
| 2017 Q1 | 15.63 Billion JPY | 3.24% |
| 2017 Q4 | 15.01 Billion JPY | -2.78% |
| 2017 Q3 | 15.44 Billion JPY | -0.38% |
| 2017 Q2 | 15.49 Billion JPY | -0.9% |
| 2017 FY | 15.01 Billion JPY | -0.9% |
| 2016 Q1 | 13.76 Billion JPY | 3.18% |
| 2016 Q4 | 15.14 Billion JPY | 5.92% |
| 2016 Q3 | 14.3 Billion JPY | 2.32% |
| 2016 Q2 | 13.97 Billion JPY | 1.55% |
| 2016 FY | 15.14 Billion JPY | 13.54% |
| 2015 Q3 | 14.1 Billion JPY | -0.32% |
| 2015 FY | 13.34 Billion JPY | 3.35% |
| 2015 Q4 | 13.34 Billion JPY | -5.44% |
| 2015 Q2 | 14.15 Billion JPY | 1.02% |
| 2015 Q1 | 14.01 Billion JPY | 8.54% |
| 2014 Q2 | 13.62 Billion JPY | -2.0% |
| 2014 Q4 | 12.9 Billion JPY | -6.07% |
| 2014 FY | 12.9 Billion JPY | 2.75% |
| 2014 Q3 | 13.74 Billion JPY | 0.85% |
| 2014 Q1 | 13.9 Billion JPY | 10.67% |
| 2013 Q2 | 13.91 Billion JPY | 4.48% |
| 2013 Q3 | 13.71 Billion JPY | -1.47% |
| 2013 Q4 | 12.56 Billion JPY | -8.38% |
| 2013 FY | 12.56 Billion JPY | 6.92% |
| 2013 Q1 | 13.32 Billion JPY | 13.36% |
| 2012 Q1 | 13.57 Billion JPY | 11.79% |
| 2012 Q3 | 12.96 Billion JPY | 0.92% |
| 2012 Q2 | 12.84 Billion JPY | -5.32% |
| 2012 FY | 11.75 Billion JPY | -3.2% |
| 2012 Q4 | 11.75 Billion JPY | -9.37% |
| 2011 Q1 | 13.13 Billion JPY | 15.45% |
| 2011 Q4 | 12.13 Billion JPY | -5.64% |
| 2011 FY | 12.13 Billion JPY | 6.74% |
| 2011 Q3 | 12.86 Billion JPY | 1.1% |
| 2011 Q2 | 12.72 Billion JPY | -3.08% |
| 2010 Q3 | 12.06 Billion JPY | 0.27% |
| 2010 Q4 | 11.37 Billion JPY | -5.75% |
| 2010 FY | 11.37 Billion JPY | -5.1% |
| 2010 Q1 | 11.96 Billion JPY | -0.13% |
| 2010 Q2 | 12.03 Billion JPY | 0.56% |
| 2009 Q2 | 10.94 Billion JPY | 0.0% |
| 2009 Q4 | 11.98 Billion JPY | -6.51% |
| 2009 Q3 | 12.81 Billion JPY | 17.09% |
| 2009 FY | 11.98 Billion JPY | 26.8% |
| 2008 Q3 | 8.63 Billion JPY | 0.0% |
| 2008 Q4 | 9.45 Billion JPY | 9.46% |
| 2008 FY | 9.45 Billion JPY | 86.01% |
| 2007 FY | 5.08 Billion JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 16.89 Billion JPY | -0.533% |
| Takeda Pharmaceutical Company Limited | 4843.75 Billion JPY | 99.649% |
| Sumitomo Pharma Co., Ltd. | 418.88 Billion JPY | 95.946% |
| Shionogi & Co., Ltd. | 11.62 Billion JPY | -46.136% |
| Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -16791.643% |
| Nippon Shinyaku Co., Ltd. | 2.87 Billion JPY | -491.26% |
| Kaken Pharmaceutical Co., Ltd. | 3.85 Billion JPY | -341.065% |
| Eisai Co., Ltd. | 206.74 Billion JPY | 91.787% |
| Morishita Jintan Co., Ltd. | 425 Million JPY | -3895.529% |
| Hisamitsu Pharmaceutical Co., Inc. | 2.1 Billion JPY | -708.619% |
| Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -4501.897% |
| Fuso Pharmaceutical Industries,Ltd. | 12.72 Billion JPY | -33.477% |
| Tsumura & Co. | 79.69 Billion JPY | 78.691% |
| Kissei Pharmaceutical Co., Ltd. | 1.72 Billion JPY | -883.266% |
| Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -6859.426% |
| Towa Pharmaceutical Co., Ltd. | 202.35 Billion JPY | 91.608% |
| Fuji Pharma Co., Ltd. | 28.94 Billion JPY | 41.34% |
| Zeria Pharmaceutical Co., Ltd. | 47.58 Billion JPY | 64.315% |
| KYORIN Holdings, Inc. | 20.94 Billion JPY | 18.93% |
| Taiko Pharmaceutical Co.,Ltd. | 3.8 Billion JPY | -345.813% |
| Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | -94.759% |
| SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
| MedRx Co., Ltd | - JPY | -Infinity% |
| Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
| Solasia Pharma K.K. | 60 Million JPY | -28201.667% |
| Modalis Therapeutics Corporation | 412.5 Million JPY | -4016.606% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | -79.03% |
| Sawai Group Holdings Co., Ltd. | 82.89 Billion JPY | 79.514% |
| Cyfuse Biomedical K.K. | 913 Million JPY | -1759.912% |
| Toho Holdings Co., Ltd. | 30.24 Billion JPY | 43.853% |
| Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | -501.036% |